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Abstract
Background: Most comprehensive geriatric assessment (CGA) programs refer to hospital-based
settings. However the body of geriatric healthcare is provided by general practitioners in their
office. Structured geriatric problem detection by means of assessment instruments is crucial for
efficient geriatric care giving in the community.
Methods: We developed and pilot tested a German language geriatric assessment instrument
adapted for general practice. Nine general practices in a rural region of Austria participated in this
cross-sectional study and consecutively enrolled 115 persons aged over 75 years. The prevalence
of specific geriatric problems was assessed, as well as the frequency of initiated procedures
following positive and negative tests. Whether findings were new to the physician was studied
exemplarily for the items visual and hearing impairment and depression. The acceptability was
recorded by means of self-administered questionnaires.
Results: On average, each patient reported 6.4 of 14 possible geriatric problems and further
consequences resulted in 43.7% (27.5% to 59.8%) of each problem.
The items with either the highest prevalence and/or the highest number of initiated actions by the
GPs were osteoporosis risk, urinary incontinence, decreased hearing acuity, missing pneumococcal
vaccination and fall risk. Visual impairment was newly detected in only 18% whereas hearing
impairment and depression was new to the physician in 74.1% and 76.5%, respectively.
A substantial number of interventions were initiated not only following positive tests (43.7% per
item; 95% CI 27.5% to 59.8%), but also as a consequence of negative test results (11.3% per item;
95% CI 1.7% to 20.9%).
The mean time expenditure to accomplish the assessment was 31 minutes (SD 10 min). Patients
(89%) and all physicians confirmed the CGA to provide new information in general on the patient's
health status. All physicians judged the CGA to be feasible in everyday practice.
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Conclusion: This adapted CGA was feasible and well accepted in the general practice sample.
High frequencies of geriatric problems were detected prompting high numbers of problem-solving
initiatives. But a substantial number of actions of the physicians following negative tests point to the
risks of too aggressive treatment of elderly patients with possibly subsequent negative effects.
Background
In the Austrian health care system, general practitioners
provide care for more than 90% of the population aged
over 75 years. For general practitioners in rural as well as
urban regions, effective support strategies for geriatric
patient problems are indispensable.
From studies several decades ago it is known that high
numbers of undetected problems exist in elderly people,
highlighting the need for a systematic approach to geriat-
ric problem detection [1,2]. Subsumed as comprehensive
geriatric assessment (CGA) many initiatives have been
started within the last years [3-5]. Today evidence from
randomised controlled trials or systematic reviews on
CGA is increasingly available, supporting the use of hos-
pital-based programs with extended ambulatory follow-
up [6] and preventive home visits based on CGA with
multiple follow-up [7,8]. The study samples refer to hos-
pital-based and long term multidimensional care settings,
performed by groups of geriatricians, geriatric nurses or
other specialised health care providers. But working con-
ditions in the general practitioners' offices and the charac-
teristics of a community dwelling geriatric population
differ from the settings providing the main evidence up to
now.
Therefore, for the implementation of such an instrument
in general practice, it is important to recognize the special
requirements of the primary care setting. Limited consul-
tation time and small office staffs can cause problems for
the adoption of the CGA. Thus, for the use in primary care,
the CGA should be concise, easy to perform and take no
more than 30 minutes [9,10].
The aim of our study was to adapt and pilot a CGA instru-
ment in German Language, to measure the prevalence of
specific geriatric socio-medical problems in the Austrian
senior population and to analyse the subsequent manage-
ment applied by the primary care physicians. The instru-
ment was to be tested regarding its applicability in daily
practice and its acceptability for patients and physicians.
Methods
Study design and participants
We performed a cross-sectional study in nine general prac-
tices in Vorarlberg, a rural area of Austria. All general prac-
titioners recruited built a convenience sample from a
management quality circle.
Patients were equally recruited from all practices. Eligibil-
ity criteria were: age over 75 years and the capability to
attend the GPs office. We excluded persons with a termi-
nal illness or with a known pre-existing diagnosis of
severe dementia. These criteria focused on elderly patients
who would most likely benefit from CGA [8]. Patients
were assigned prospectively and consecutively to the
study, which took place between December 2001 and
April 2002. All patients gave written informed consent
and agreed to schedule an appointment in the next days
for fasting laboratory tests and for the assessment.
Screening instrument
The screening instrument was developed by reviewing the
literature with focus on the most common socio-medical
geriatric health problems regarding epidemiology and
treatment options [5,7,9,11]. Table 1 shows the assess-
ment checklist with the covered areas. For each category
we gave pre-specified answers with cut-off values for pos-
itive and negative screening tests. For the subsequent
management of positive findings, we proposed common-
practice problem solving strategies.
We collected information from the physicians on whether
a finding was new to them in an exemplary subset of the
variables visual acuity, hearing acuity and depression. We
did not collect data on new diagnoses for all clinical
domains, because our primary aim was a systematic
inventory taking of geriatric problems and its feasibility in
the primary care setting.
Prior to the start of the study we gave an introduction of 6
hours to all participating GPs' on the use of the assess-
ment instrument.
Physicians' acceptability
All physicians recorded their time expenditure to com-
plete the screening assessment. Any further actions
invoked within the assessment were not part of the time
measurement. We recorded the acceptability of the CGA
by the practitioners with a self-administered question-
naire. Physicians specified whether the CGA revealed new
information about their patients, whether they had any
suggestions for improving the CGA and whether they per-
ceived the CGA to be suitable for the general practice
setting.BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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Table 1: Geriatric assessment chart
Target problem Diagnostic test Cut-off value Management strategies
Visual acuity Jaeger's test [37] ≤20/40 Referral to ophthalmologist
Hearing acuity Whisper test [38] Failure to correctly repeat 3 whispered 
numbers
Removal of ear wax
Referral to otolaryngologist
Urinary 
incontinence
IKO-4-Test [39] 4 defined questions ≥1 question 
answered positive
Change of existing drug prescription
Pelvic floor muscle training
Drug treatment
Planning of in-depth exploration by GP
Referral to urologist or gynaecologist
Depression Geriatric depression scale, short 
version (GDS 4) [33]
4 defined questions ≥1 question 
answered positive
New antidepressant drug therapy
Change of drug prescription
Non-drug treatment strategy
Planning of in-depth exploration by GP
Referral to psychiatrist
Cognitive 
impairment
Memory Assessment Clinics 
Questionnaire (MAC-Q) [40]
6 defined questions (Score range 7 – 35) 
Score ≥25 suggestive of cognitive 
impairment
Follow-up examination in 6 months¶ 
Referral for memory assessment to 
neurologist or psychiatrist
ADL and IADL † Katz's ADL scale (4 questions) [41]
Two questions from Lawton [42]
Score ≤7 impairment of functioning in 
daily living (total score 0–9).
Planning of in-depth exploration by GP
Referral according to underlying problem
Psychosocial 
circumstances
Do you have trustworthy persons 
giving you assistance at home? [43]
Yes/No Contact with community nurse, 
neighbours or relatives
Sleep disorder Do you suffer from frequent sleeping 
problems?
Yes/No Non-Drug therapy
Change of drug prescription
Drug treatment
Planning of in-depth exploration by GP
Referral to psychiatrist/internist.
Influenza and 
pneumococcal 
Immunisation
Influenza vaccination within a one-year 
period [24]
Pneumococcal vaccination within a 
three-year period [44]
Yes/No Influenza or pneumococcal vaccination
Fall risk 
assessment
History of falls
Timed Up and Go Test [45]
Tandem – Stand Test [46]
Fall within last 6 months
>20 s suggestive of balance or gait 
difficulties
Score 0–4: >1 suggestive of balance or 
gait difficulty
Exploration of drug prescription
Hip protector
Source exploration
Replacement of footwear initiated
Instructed exercise training
Cardiovascular 
risk assessment
Lipid profile (mmol/l) [47,48]
Blood pressure (mm Hg) [50]
Hyperglycemia [51]
Chol > 5.95 mmol/l
LDL > 3.36 mmol/l
HDL < 1.16 mmol/l
TG > 4.6 mmol/l
BPsyst > 140 mmHg
BPdiast > 80 mmHg
Fasting blood glucose > 6.1 mmol/l
Change or onset of antilipidemic drug 
treatment
Change or onset of antihypertensive drug 
treatment
Change or onset of oral antidiabetic drug 
or insulin
Medication 
history
Number of prescribed drugs
Number of over the counter 
medications [43]
>5 prescription drugs
>3 over the counter drugs.
Hospital stay Hospital stay within a 5-months period 
[43]
Nutrition Body mass index BMI normal range for the elderly 24 – 
29, Waid Guide [52]
Planning of in-depth exploration by GP
Osteoporosis risk 
factors
9 items risk factor checklist [53] Female sex
Prior spontaneous fracture
Family history of osteoporosis
Immobilisation
Premature menopause
Glucocorticoid treatment
Smoking
Alcohol abuse
Low body weight
Calcium and Vitamin D
Bisphosophonate
Selective estrogen-receptor modulator
Calcitonin
† Basic and instrumental activities of daily living. ¶ Only for borderline cases (MAC-Q 22–24 points)BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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Patients' acceptability
We collected data on the patients' perception of the CGA
equally by means of a self-administered questionnaire.
Patients specified 1. whether they received new informa-
tion on their health status 2. whether they considered
annual follow-ups of the CGA to be beneficial for their
well-being 3. The willingness to pay personally for the
health assessment 4. whether they felt embarrassed about
the detailed assessment 5. whether the CGA missed any
important health issues.
Data on patient acceptability were collected during and
after performance of the CGA and either returned to the
GP directly or sent to the study coordinator by post. Data
were collected only once, follow-up data are not available.
Data analysis
Disease prevalence of this descriptive analysis is estimated
by the number of people with a positive screening test out
of those examined. Further, any diagnostic or treatment
efforts taken by the primary care physicians were analysed
in relation to positive or negative screening results by
means of 2 × 2 contingency tables for each screening item.
We supposed that screening items which are practically
relevant for the physicians might either have a high prev-
alence and/or might be followed by a high frequency of
diagnostic or treatment efforts initiated by the GPs. To
therefore generate a rank order of more or less relevant
items, we calculated the product of the prevalence times
the total proportion of diagnostic or treatment actions ini-
tiated by the physician for each item. Items with a high
prevalence and/or a high frequency of consequences
taken by the GPs reached high product scores and were
ranked in descending order in Table 4.
We assessed associations between age (by year), sex
(female sex) and the risk for a positive screening test
fitting logistic regression models, accounting for the effect
of clustering.
Since observations on individuals within the same general
practice may be correlated, all analyses took account of
the clustering effect in the variance estimation. All analy-
ses were performed using STATA 8.0. We used the survey
method of STATA for analysis. The general practice was
the primary sampling unit.
Results
Demographic data
The study took place between December 2001 and April
2002. Nine general practitioners volunteered to take part
in the study. Their general practice experience varied
between 7 and 22 years. Three of nine were female
doctors.
124 patients were consecutively enrolled in the study; the
data from nine patients had to be excluded because of
incomplete data collection. The patients' baseline charac-
teristics are shown in Table 2.
Table 2: Patients baseline characteristics as recorded in the CGA chart (n = 115)
Age years (mean, SD) 77.9 (3.8)
Female sex (%) 85 (73.9%)
Number of geriatric problems (mean, SD) 6.4 (2.7)
Social circumstances
Living at home (No, %) 113 (98%)
Living alone (No, %) 53 (46%)
No limitations in Instrumental Activities of Daily Living (IADL) 94 (81.8%)
Hospital stay within a 5-months period 30 (26.5%)
Nutrition
BMI, mean (mean, SD) 26.4 (4.5)
Overweight (BMI > 29) 31 (27.0%)
Underweight (BMI < 24) 38 (33%)
Cardiovascular risk factors other than age ¶ 84 (73.0%)
Hypertension 68 (60.2%)
Diabetes 21 (18.6%)
Hyperlipidemia 39 (34.5%)
Smoking 7 (6.2%)
Multiple medication use
>5 prescription drugs 47 (41.2%)
>3 over the counter drugs 3 (6.3%)
Fall within a 5-months period 28 (25.0%)
¶ Refer to risk factors in the medical history of the patient known prior to CGABMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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Geriatric assessment
Table 3 shows the prevalence of each screened problem.
The frequency of any actions taken by the physicians – as
a consequence of a positive test result or following nega-
tive test results – are shown in table 4. The items in table
4 are listed in a descending rank order according to the
decreasing product score of practical relevance. The
detailed management actions undertaken by the physi-
cians irrespective of the screening result are specified in
table 5.
On average, each patient reported 6.4 of 14 possible prob-
lems. Overall diagnostic or therapeutic consequences
were taken in 23.9% per patient and test item (95% CI
13.0% to 34.7%) and in 43.7% (95% CI 27.5% to 59.8%)
following positive test results.
The test items with either the highest prevalence or the
highest proportions of actions undertaken by the GPs
were osteoporosis risk, urinary incontinence, decreased
hearing acuity, missing pneumococcal vaccination and
increased fall risk.
Table 3: Prevalence of positive assessment test results
Problem No Prevalence 95% CI
Pneumococcal vaccination longer than three years ago (n = 113) 93 82.3% 65.4 to 92.0%
Osteoporosis risk (n = 115) 81 70.4% 57.0% to 81.1%
Urinary incontinence (n = 112) 76 67.9% 53.8% to 79.3%
Hyperlipidemia at assessment (n = 113) 66 57.4% 46.7% to 67.4%
Cognitive impairment (n = 114) 63 55.2% 41.7% to 68.1%
Hearing loss (n = 114) 58 50.9% 38.7% to 62.9%
Hypertension at assessment (n = 111) 53 47.8% 28.1 to 68.1%
Last influenza vaccination longer than one year ago (n = 114) 52 45.6% 7.1% to 54.4%
Fall risk or balance and gait difficulties (n = 115) 48 41.7% 34.5 to 49.4%
Sleep disorder (n = 114) 42 36.8% 24.6% to 51.0%
Depression (n = 114) 34 29.8% 19.1% to 43.3%
Low vision (n = 110) 32 29.1% 13.8 to 51.3%
Hyperglycemia at assessment (n = 112) 28 25.0% 16.2% to 36.6%
Psychosocial deprivation (n = 113) 8 7.1% 3.1% to 15.3%
Table 4: Number of disease management actions undertaken by the GPs following positive or negative test results.
Problem Number of actions 
following positive test
Number of actions 
following negative test
Product score §
No % † 95% CI No % ‡ 95% CI
Osteoporosis risk (n = 115) 62 76.5 57.4 to 88.8 21 61.7 30.8 to 85.4 0.51
Urinary incontinence (n = 112) 51 67.1 52.2 to 79.2 3 8.3 2.6 to 23.3 0.33
Hearing loss (n = 114) 38 65.5 48.7 to 79.2 1 1.8 0.2 to 15.3 0.17
Pneumococcal vaccination longer than 3 years ago (n = 113) 19 20.4 7.2 to 46.2 4 20.0 5.8 to 50.4 0.17
Fall risk or balance and gait difficulties (n = 115) 22 45.8 28.1 to 64.7 16 23.9 7.1 to 56.3 0.14
Sleep disorder (n = 114) 31 73.8 52.0 to 88.0 2 2.8 0.6 to 28.1 0.11
Influenza vaccination longer than one year ago (n = 114) 8 15.4 2.2 to 60.4 12 19,4 7.8 to 40.6 0.08
Low vision (n = 110) 21 65.6 43.2 to 82.8 8 10.3 3.4 to 27.3 0.08
Cognitive impairment (n = 114) 12 19.1 10.3 to 32.5 1 2.0 0.2 to 17.0 0.06
Depression (n = 114) 20 58.8 29.7 to 82.9 1 1.3 0.1 to 12.6 0.05
Hyperlipidemia at assessment (n = 113) 9 13.6 5.5 to 30.0 0 0 0.04
Hypertension at assessment (n = 111) 4 7.5 3.4 to 16.0 0 0 0.02
Psychosocial deprivation (n = 113) 6 75.0 37.0 to 93.9 7 6.6 1.9 to 21.3 0.01
Hyperglycemia at assessment (n = 112) 2 7.1 1.4 to 29.4 0 0 0 0.01
§Product score to generate a rank order of practical relevance: Product of prevalence times the proportion of any actions following either positive 
or negative test results. † In relation to prevalences displayed in Table 3. ‡ In relation to negative tests [total (n) – number of positive tests] in Table 
3.BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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The items hyperlipidemia, hypertension, and hyperglyc-
emia had a fairly high prevalence, but general practition-
ers initiated further work-up's only in 1.8% to 7.9% of all
of cases.
The investigation of whether a detected problem was a
new finding for the practitioner was exemplarily done for
visual acuity, hearing acuity and depression. In only 6 of
33 cases (18.2%) visual impairment was new to the phy-
sician whereas for hearing impairment and depression
this information was new in 43 of 58 (74.1%) and 26 of
34 (76.5%) cases, respectively.
In contrast, in a substantial number of 10.7% (95% CI
0.3% to 21.0%) of all cases per item diagnostic or thera-
peutic procedures were initiated by the physicians despite
negative results in the screening. Considerable variability
existed in the number of actions following negative tests
over the different items, most important concerning oste-
oporosis risk, fall risk and the immunisation interven-
tions (Table 4).
Table 5: Frequencies of detailed management actions undertaken by the physicians following positive or negative screening tests.
Problem All actions Detailed actions ¶
No % † No % †
Osteoporosis risk assessment (n = 115) 83 72.1 DXA bone measurement 76 66.1
New prescription of Vitamin D3 and Calcium 58 50.4
New estrogen replacement therapy 1 0.9
Bisphosophonate 22 19.1
Calcitonin 0 0
Selective estrogen-receptor modulator therapy 1 0.9
Urinary incontinence (n = 112) 54 47.0 Pelvic floor muscle training 21 18.8
Change of drug prescription 7 6.3
Planning of in depth exploration by GP 17 15.2
New drug prescription 15 13.4
Referral to urologist or gynaecologist 11 9.8
Hearing loss (n = 114) 39 33.9 Removal of ear wax 15 13.2
Referral to otolaryngologist 29 25.4
Fall risk or balance and gait difficulties (n = 115) 38 33.1 Change of drug prescription 4 3.5
Hip protector 3 2.6
Environmental source exploration 20 17.4
Information on safer footwear 25 21.7
Instructed exercise training 7 6.1
Planning of in-depth exploration by GP 5 4.3
Sleep disorder (n = 114) 33 28.7 New drug prescription 16 14.0
Change of drug prescription 2 1.8
Non- drug therapy 13 11.4
Planning of in-depth exploration by GP 5 4.4
Low vision (n = 110) 29 26.4 Referral to ophthalmologist 29 26.4
Pneumococcal vaccination longer than 3 years ago (n = 113) 23 20.0 Pneumococcal vaccination 23 20.4
Depression (n = 114) 21 18.3 New antidepressant drug therapy 7 6.1
Change of drug prescription 2 1.8
Non-drug treatment 10 8.8
Planning of in-depth exploration by GP 9 7.9
Referral to psychiatrist 1 0.9
Influenza vaccination longer than one year ago (n = 114) 20 17.4 Influenza vaccination 20 17.4
Psychosocial deprivation (n = 113) 14 12.3 Contact with relatives 7 6.1
Contact with neighbours 4 3.5
Contact with community nurse 6 5.3
Contact with social worker 1 0.9
Cognitive impairment (n = 114) 13 11.4 Follow up in six months 37 32.5
Referral to neurologist/psychiatrist 13 11.4
Hyperlipidemia at assessment (n = 113) 9 7.9 Antilipidemic drug treatment 9 7.9
Hypertension at assessment (n = 111) 4 3.6 New or additional drug prescription 4 3.6
Hyperglycemia at assessment (n = 112) 2 1.8 New or additional drug prescription 2 1.8
† Percentage related to all participants ¶ Multiple notations possibleBMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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Significant associations between sex, age and the particu-
lar screening item are illustrated in Table 6, non-signifi-
cant associations are omitted. For every significant
association, female patients were clearly at higher risk,
after controlling for age. This finding was most obvious
for depression.
Physicians' acceptability of geriatric assessment
The mean time expenditure to solely accomplish the
entire geriatric assessment was 31 minutes (SD 10 min),
with a minimal requirement of 18 minutes to a maximum
of 45 minutes.
All nine physicians confirmed that the geriatric assess-
ment provided new information in general on their
patients' health status and that it was feasible in everyday
practice. By comments, three of the nine practitioners
mentioned that the screening of dementia by means of the
MAC-Q Test is inadequate.
Patients' acceptability of geriatric assessment
All but four patients returned the self-administered ques-
tionnaire. 99 (89%) of 111 patients estimated the CGA to
be potentially supportive for their health condition and
well-being; the remaining 11% were sceptical or negative.
In 55%, patients stated the CGA to provide new informa-
tion on their health status, mainly in the area of sensomo-
tory dysfunction (vision, hearing), cognitive impairment
and osteoporosis risk. 103 of 111 (93%) wished to attend
regular CGA follow-up assessments and 62 of 111 (56%)
confirmed the willingness to pay personally for it. The
most commonly mentioned missing topics from the
patients' point of view were dental health, sexuality,
tremor and joint affections. Only a minority of four
patients felt embarrassed by the examination.
Discussion
We have presented the results of a Pilot-Initiative to
implement a multidimensional geriatric assessment
instrument in a general-practice population in Vorarlberg,
Austria. This German-Language instrument was tailored
for the use in the GP's office.
Six out of 14 geriatric health problems were identified on
average in each patient and nearly half of the positive test
items led the physician to take further actions. However
initiatives taken by the physicians strongly depend on
whether patient problems were previously known or not.
We did not systematically score new findings as such
throughout the assessment because the primary goal was
to test feasibility and focused on initial problem inventory
taking. Exemplarily we investigated the gain of new infor-
mation for the items vision, hearing and depression and
found considerable variation ranging from a proportion
of only 18% of new cases for low vision up to 76% for
depression. Junius [12-14] reported that less than half of
registered health problems in a CGA were known to the
GP's.
Osteoporosis risk, urinary incontinence, reduced hearing
acuity, missing pneumococcal vaccination and fall risk
were the problems with either the highest prevalence or
highest frequency of initiated steps by the physicians.
Mainly items on functional impairment and prevention
resulted in high number of initiatives taken by the
doctors. We suggest that these aspects of the assessment
yielded new information on patient problems because
these aspects are not usually covered in routine visits to
the GP. In contrast, few diagnostic or therapeutic conse-
quences were initiated after GPs detected hyperlipidemia,
hypertension or hyperglycemia, despite considerable
prevalence rates. We are not able to specify on the basis of
our data why a certain discrepancy was found between
higher proportions of actions taken after the detection of
functional impairment or missing preventive measures
(e.g. vaccination) than after measuring pathologic values
of plasma lipids, blood pressure or blood glucose. We sug-
gest that physicians have a rather critical attitude towards
interventions aiming to increase life expectancy. In addi-
tion caution towards risks of multiple medication use or
over-treatment might have been an important reason for
Table 6: Independent significant associations of risk of the particular screening item by age and sex
Screening item Age Female sex
Odds ratio * 95% CI Odds ratio * 95% CI
Fall risk 1.11 1.001 to 1.23 2.15 1.06 to 4.37
Cognitive impairment n.s. 2.28 1.10 to 4.73
Depression n.s. 5.16 1.64 to 16.25
Visual impairment 1.18 1.04 to 1.34 2.93 1.29 to 6.68
* Odds ratios are deviated from logistic regression models taking into account cluster sample design. They represent the increased odds of being at 
risk for a presented item associated with age (by each year) or by being female.BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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the restricted use of for example lipid lowering agents
[15]. Also a single elevated blood pressure value or ele-
vated fasting blood glucose measurement was not consid-
ered to justify an immediate drug therapy in every case
and may explain the limited initiatives of the GPs' towards
these positive test findings. Nevertheless, the study popu-
lation consisted of a rather fit group of independent com-
munity-dwelling elderly and in certain cases starting
treatment can be justified (e.g. combination of cardiovas-
cular risk factors) [16].
We found a high number of actions taken to further assess
and treat osteoporosis. In two thirds of all participants
DEXA bone measurements were initiated, mainly in
women and in singular cases of men at risk (e.g. corticos-
teroid treatment). But the proportion of DEXA orders var-
ied considerably between physicians. According to the
SCORE [17,18] and ORAI [18,19] decision rules, elderly
female patients within the CGA basically qualify for BMD
measurements, but no clear recommendations exist for
men [20]. This high number of performed BMD tests dur-
ing the assessment may reflect a study effect rather than
the real attitude of primary care physicians towards BMD-
tests. The between-physician variation in the frequency of
testing for osteoporosis points towards the problems
among family physicians on the management of oste-
oporosis and on the educational needs on osteoporosis
management in primary care [21].
Pneumococcal and influenza vaccinations are widely rec-
ommended preventive actions in the elderly population
in many European countries and the USA [22-24]. The
level of vaccination in our population considerably dif-
fered between the flu shot (54%) and pneumococcal vac-
cination (18%). The data are similar to other German-
speaking countries [25], but are low compared to US rates
[26,27]. The difference in the coverage between influenza
and pneumococcal vaccination in our population reflects
the lower acceptance for the pneumococcal vaccine. Pro-
motion for pneumococcal vaccination was being per-
formed only recently [28].
For cognitive impairment patients were referred to spe-
cialists in 19% of positive results. For most patients physi-
cians ordered a follow-up after six months although in the
protocol a simple follow-up was proposed only for bor-
derline cases (MAC-Q 22–24 points). Participating GPs
reported to refrain from undertaking further steps because
of limited treatment options [29].
Fall risk was prevalent in nearly half of all patients and
was followed in nearly half of all positive cases. Patients'
low compliance for exercise programs and hip protectors
was the reason for low treatment rates [30].
Hearing was more commonly impaired than vision
[31,32]. Vision was tested with corrective lenses in most
cases whereas acoustically impaired patients were
equipped with hearing aids only rarely.
Positive testing for depression was identified in up to one
third of the senior population and it was strongly associ-
ated with the female sex, but not age. We incorporated the
GDS-4, a short version of the GDS-15 in the CGA. With a
sensitivity of 89% and specificity 65% most patients are
identifiable, depending on the severity of the condition
[33]. Within the study setting physicians were aware not
to miss this treatable condition and judged further efforts
necessary in about 60% of positively screened cases. This
exceeds the generally low number for referral or treatment
for depression in general practice [34].
Compared to other prevalence studies in the elderly 75+
primary care population in Europe [35] we saw broadly
about twofold higher prevalences of common problems
in our setting, although we assume to have assessed a
rather fit elderly population. Not population differences
but rather the sensitivity and specificity of the different
screening tests might explain the discrepancy. Within the
framework of the geriatric screening, the instrument
should be simple and easy to handle in general practice,
but at the expense of perhaps a substantial number of
false positive results leading to over-diagnosis and the risk
of over-treatment.
A considerable proportion of diagnostic or therapeutic
consequences were initiated even though negative test
results had been recorded. In fact for the items osteoporo-
sis risk, fall risk, lack of influenza or pneumococcal vacci-
nation and low vision consequences following negative
results were ascertained in 10% up to 62%. Hence some
physicians have expanded their efforts after negative tests
what might reflect some lack of trust of the GPs' in CGA
although impeccable scores of acceptability were quoted
in the questionnaire. In addition, patients might have
complained about symptoms outside the protocol lead-
ing to further interventions. Generally this finding points
to a risk that through the accomplishment of CGAs some
physicians tend towards over-treatment of elderly patients
with potential negative side-effects.
In our population of relatively fit seniors, CGA was wel-
comed by most patients and physicians as a part of regular
health checks. CGA, requiring about half an hour of con-
sultation time was judged to be feasible in daily practice
routine. But the time expenditure to initiate further, espe-
cially complex work-up is not accounted for in this half an
hour. According to patients, we missed important screen-
ing items like dental health, sexuality, tremor and joint
affections.BMC Geriatrics 2004, 4 http://www.biomedcentral.com/1471-2318/4/4
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Further research should focus on the effectiveness of sys-
tematic screening as well as on potential negative effects
like over-diagnosis, labelling and over-treatment of geriat-
ric patients through CGAs. The MRC-Trial of assessment
and management of older people in the community
addresses these questions of effectiveness and its results
will bring further clarity [36]. The validation of a German
instrument should include effectiveness and practical rel-
evance, as pointed out in this study.
Limitations
Cognitive impairment was found in 55% of all partici-
pants screened and restrictions apply either to the MAC-Q
test with a high false-positive rate or test results requiring
intellectual or memory capacities must be interpreted
with caution.
Statements on the physicians' acceptability might be gen-
eralised only with restriction, because the participating
physicians are a convenience sample of physicians with a
higher than average interest in geriatric health care
problems.
We performed no follow-up assessments. Repeated meas-
urements of the score of patient consent and physicians'
acceptability during follow-up would add import infor-
mation. Patients experiencing side effects of over-eager
doctors, of embarrassing diagnostic procedures or limited
therapeutic possibilities might criticize the CGA later
resulting in decreasing patient consent.
Conclusion
Our pilot study showed that an adapted version of a CGA
detects a high prevalence of geriatric problems prompting
a high number of consecutive diagnostic and therapeutic
interventions mainly in the field of functional impair-
ment and prevention. It is applicable in general practice
and shows good acceptability. Physicians ostensibly
appreciate being guided by the CGA but in some aspects
preserve autonomy for decision making.
The CGA should not be seen as an isolated screening
instrument, but rather as a clinical checklist to approach
elderly patients in general practice. There might be a pos-
itive impact on quality of life, but on the same time it car-
ries the risk of side effects of over-diagnosis and too
aggressive treatment.
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